| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
AAMP
|
angio-associated, migratory cell protein
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACKR4
|
atypical chemokine receptor 4
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADD2
|
adducin 2 (beta)
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADM2
|
adrenomedullin 2
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIPL1
|
aryl hydrocarbon receptor interacting protein-like 1
|
|
AIRE
|
autoimmune regulator
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKAP5
|
A kinase (PRKA) anchor protein 5
|
|
AKAP6
|
A kinase (PRKA) anchor protein 6
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALKBH5
|
AlkB family member 5, RNA demethylase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPK1
|
alpha-kinase 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle)
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANOS1
|
anosmin 1
|
|
ANXA1
|
annexin A1
|
|
ANXA5
|
annexin A5
|
|
ANXA7
|
annexin A7
|
|
APC
|
adenomatous polyposis coli
|
|
APCS
|
amyloid P component, serum
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLF
|
aprataxin and PNKP like factor
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGEF11
|
Rho guanine nucleotide exchange factor (GEF) 11
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB1
|
arrestin, beta 1
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASB3
|
ankyrin repeat and SOCS box containing 3
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BANF1
|
barrier to autointegration factor 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCAS3
|
breast carcinoma amplified sequence 3
|
|
BCCIP
|
BRCA2 and CDKN1A interacting protein
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC6
|
baculoviral IAP repeat containing 6
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BPIFB1
|
BPI fold containing family B, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator)
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
C19ORF48
|
chromosome 19 open reading frame 48
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C3
|
complement component 3
|
|
C3AR1
|
complement component 3a receptor 1
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C5AR2
|
complement component 5a receptor 2
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALR
|
calreticulin
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CANX
|
calnexin
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASP12
|
caspase 12 (gene/pseudogene)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CCDC110
|
coiled-coil domain containing 110
|
|
CCK
|
cholecystokinin
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL16
|
chemokine (C-C motif) ligand 16
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD1B
|
CD1b molecule
|
|
CD1D
|
CD1d molecule
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD207
|
CD207 molecule, langerin
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD300C
|
CD300c molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD48
|
CD48 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD5L
|
CD5 molecule-like
|
|
CD69
|
CD69 molecule
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD83
|
CD83 molecule
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CERS1
|
ceramide synthase 1
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA2
|
cholinergic receptor, nicotinic, alpha 2 (neuronal)
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIB2
|
calcium and integrin binding family member 2
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CIZ1
|
CDKN1A interacting zinc finger protein 1
|
|
CLCA1
|
chloride channel accessory 1
|
|
CLDN11
|
claudin 11
|
|
CLDN4
|
claudin 4
|
|
CLEC12A
|
C-type lectin domain family 12, member A
|
|
CLEC2B
|
C-type lectin domain family 2, member B
|
|
CLEC2D
|
C-type lectin domain family 2, member D
|
|
CLEC4C
|
C-type lectin domain family 4, member C
|
|
CLEC4E
|
C-type lectin domain family 4, member E
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLEC9A
|
C-type lectin domain family 9, member A
|
|
CLU
|
clusterin
|
|
CNN3
|
calponin 3, acidic
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPA3
|
carboxypeptidase A3 (mast cell)
|
|
CPM
|
carboxypeptidase M
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRLF1
|
cytokine receptor-like factor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CS
|
citrate synthase
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
CST3
|
cystatin C
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSC
|
cathepsin C
|
|
CTSG
|
cathepsin G
|
|
CTTN
|
cortactin
|
|
CUL5
|
cullin 5
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
CYTH1
|
cytohesin 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DBNL
|
drebrin-like
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX42
|
DEAD (Asp-Glu-Ala-Asp) box helicase 42
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEPTOR
|
DEP domain containing MTOR-interacting protein
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DNM1
|
dynamin 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRAM1
|
DNA-damage regulated autophagy modulator 1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DSG1
|
desmoglein 1
|
|
DSG3
|
desmoglein 3
|
|
DTNA
|
dystrobrevin, alpha
|
|
DUOX1
|
dual oxidase 1
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DZIP3
|
DAZ interacting zinc finger protein 3
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGR1
|
early growth response 1
|
|
EGR3
|
early growth response 3
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4E2
|
eukaryotic translation initiation factor 4E family member 2
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
EMD
|
emerin
|
|
EMP2
|
epithelial membrane protein 2
|
|
ENC1
|
ectodermal-neural cortex 1 (with BTB domain)
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPHB6
|
EPH receptor B6
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB2IP
|
erbb2 interacting protein
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERLEC1
|
endoplasmic reticulum lectin 1
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ERVK-7
|
endogenous retrovirus group K, member 7
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESM1
|
endothelial cell-specific molecule 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAF2
|
Fas associated factor family member 2
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLIM1
|
filamin binding LIM protein 1
|
|
FBXL5
|
F-box and leucine-rich repeat protein 5
|
|
FBXO32
|
F-box protein 32
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FDCSP
|
follicular dendritic cell secreted protein
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGG
|
fibrinogen gamma chain
|
|
FH
|
fumarate hydratase
|
|
FHL1
|
four and a half LIM domains 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMOD
|
fibromodulin
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FOXP4
|
forkhead box P4
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FPR3
|
formyl peptide receptor 3
|
|
FREM1
|
FRAS1 related extracellular matrix 1
|
|
FRZB
|
frizzled-related protein
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FSTL1
|
follistatin-like 1
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FZD4
|
frizzled class receptor 4
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB3
|
GRB2-associated binding protein 3
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALNT2
|
polypeptide N-acetylgalactosaminyltransferase 2
|
|
GAST
|
gastrin
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GBP5
|
guanylate binding protein 5
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF2
|
growth differentiation factor 2
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA4
|
gap junction protein, alpha 4, 37kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJD2
|
gap junction protein, delta 2, 36kDa
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLP2R
|
glucagon-like peptide 2 receptor
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GMFB
|
glia maturation factor, beta
|
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNB5
|
guanine nucleotide binding protein (G protein), beta 5
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like)
|
|
GPR4
|
G protein-coupled receptor 4
|
|
GPR55
|
G protein-coupled receptor 55
|
|
GPR65
|
G protein-coupled receptor 65
|
|
GPR68
|
G protein-coupled receptor 68
|
|
GPR83
|
G protein-coupled receptor 83
|
|
GPRASP1
|
G protein-coupled receptor associated sorting protein 1
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRM6
|
glutamate receptor, metabotropic 6
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
HARS
|
histidyl-tRNA synthetase
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBB
|
hemoglobin, beta
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HCRTR2
|
hypocretin (orexin) receptor 2
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC9
|
histone deacetylase 9
|
|
HERC5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H2BB
|
histone cluster 3, H2bb
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA9
|
homeobox A9
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HRH2
|
histamine receptor H2
|
|
HRH4
|
histamine receptor H4
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSF2
|
heat shock transcription factor 2
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HSPH1
|
heat shock 105kDa/110kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HUWE1
|
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDDM7
|
insulin-dependent diabetes mellitus 7
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IDS
|
iduronate 2-sulfatase
|
|
IER3
|
immediate early response 3
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNL4
|
interferon, lambda 4 (gene/pseudogene)
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17C
|
interleukin 17C
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL19
|
interleukin 19
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL21R
|
interleukin 21 receptor
|
|
IL22
|
interleukin 22
|
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL25
|
interleukin 25
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL37
|
interleukin 37
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ING2
|
inhibitor of growth family, member 2
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
ITPKA
|
inositol-trisphosphate 3-kinase A
|
|
ITPKB
|
inositol-trisphosphate 3-kinase B
|
|
ITPKC
|
inositol-trisphosphate 3-kinase C
|
|
JAK1
|
Janus kinase 1
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA0226
|
KIAA0226
|
|
KIF11
|
kinesin family member 11
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KSR1
|
kinase suppressor of ras 1
|
|
LACRT
|
lacritin
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LAT
|
linker for activation of T cells
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
|
|
LILRA6
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPAR5
|
lysophosphatidic acid receptor 5
|
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRPAP1
|
low density lipoprotein receptor-related protein associated protein 1
|
|
LRPPRC
|
leucine-rich pentatricopeptide repeat containing
|
|
LRRC19
|
leucine rich repeat containing 19
|
|
LRRC4
|
leucine rich repeat containing 4
|
|
LRRC70
|
leucine rich repeat containing 70
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LTF
|
lactotransferrin
|
|
LY96
|
lymphocyte antigen 96
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA6
|
melanoma antigen family A6
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MATK
|
megakaryocyte-associated tyrosine kinase
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MB21D1
|
Mab-21 domain containing 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCPH1
|
microcephalin 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106A
|
microRNA 106a
|
|
MIR130A
|
microRNA 130a
|
|
MIR132
|
microRNA 132
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR200C
|
microRNA 200c
|
|
MIR203A
|
microRNA 203a
|
|
MIR206
|
microRNA 206
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR221
|
microRNA 221
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR26A2
|
microRNA 26a-2
|
|
MIR29A
|
microRNA 29a
|
|
MIR320D1
|
microRNA 320d-1
|
|
MIR34A
|
microRNA 34a
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR92B
|
microRNA 92b
|
|
MIRLET7B
|
microRNA let-7b
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MRC1
|
mannose receptor, C type 1
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSH2
|
mutS homolog 2
|
|
MSH5
|
mutS homolog 5
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MSTN
|
myostatin
|
|
MT1F
|
metallothionein 1F
|
|
MTA1
|
metastasis associated 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
MYLK
|
myosin light chain kinase
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
|
NACA
|
nascent polypeptide-associated complex alpha subunit
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
|
NLRC5
|
NLR family, CARD domain containing 5
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
|
NLRP10
|
NLR family, pyrin domain containing 10
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRX1
|
NLR family member X1
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
NPY4R
|
neuropeptide Y receptor Y4
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NRROS
|
negative regulator of reactive oxygen species
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
|
NUP98
|
nucleoporin 98kDa
|
|
OA1
|
Osteoarthritis QTL 1
|
|
OASL
|
2'-5'-oligoadenylate synthetase-like
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPN4
|
opsin 4
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRL1
|
opiate receptor-like 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORM1
|
orosomucoid 1
|
|
ORM2
|
orosomucoid 2
|
|
OSBPL1A
|
oxysterol binding protein-like 1A
|
|
OSCAR
|
osteoclast associated, immunoglobulin-like receptor
|
|
OSM
|
oncostatin M
|
|
OTUD5
|
OTU deubiquitinase 5
|
|
OTUD7B
|
OTU deubiquitinase 7B
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PACSIN1
|
protein kinase C and casein kinase substrate in neurons 1
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PANX1
|
pannexin 1
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCGF2
|
polycomb group ring finger 2
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDYN
|
prodynorphin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PER1
|
period circadian clock 1
|
|
PER3
|
period circadian clock 3
|
|
PGLYRP2
|
peptidoglycan recognition protein 2
|
|
PGR
|
progesterone receptor
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIAS2
|
protein inhibitor of activated STAT, 2
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G4B
|
phospholipase A2, group IVB (cytosolic)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLEKHF2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2
|
|
PLN
|
phospholamban
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PML
|
promyelocytic leukemia
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNOC
|
prepronociceptin
|
|
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
PPAPDC2
|
phosphatidic acid phosphatase type 2 domain containing 2
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme
|
|
PPP3R1
|
protein phosphatase 3, regulatory subunit B, alpha
|
|
PPP4C
|
protein phosphatase 4, catalytic subunit
|
|
PPY
|
pancreatic polypeptide
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRELID1
|
PRELI domain containing 1
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAG3
|
protein kinase, AMP-activated, gamma 3 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRKD3
|
protein kinase D3
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRTN3
|
proteinase 3
|
|
PSD
|
pleckstrin and Sec7 domain containing
|
|
PSEN1
|
presenilin 1
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTH2R
|
parathyroid hormone 2 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTX3
|
pentraxin 3, long
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYY
|
peptide YY
|
|
PYY3
|
peptide YY, 3 (pseudogene)
|
|
QKI
|
QKI, KH domain containing, RNA binding
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis)
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFC2
|
replication factor C (activator 1) 2, 40kDa
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RHOA
|
ras homolog family member A
|
|
RHOH
|
ras homolog family member H
|
|
RIN3
|
Ras and Rab interactor 3
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic)
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNF11
|
ring finger protein 11
|
|
RNF111
|
ring finger protein 111
|
|
RNF113A
|
ring finger protein 113A
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPL29
|
ribosomal protein L29
|
|
RPS3
|
ribosomal protein S3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS9
|
ribosomal protein S9
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A7A
|
S100 calcium binding protein A7A
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
S1PR5
|
sphingosine-1-phosphate receptor 5
|
|
SAA1
|
serum amyloid A1
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCAMP3
|
secretory carrier membrane protein 3
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SECTM1
|
secreted and transmembrane 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SENP2
|
SUMO1/sentrin/SMT3 specific peptidase 2
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1
|
|
SERPINB8
|
serpin peptidase inhibitor, clade B (ovalbumin), member 8
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SESN3
|
sestrin 3
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD7
|
SET domain containing (lysine methyltransferase) 7
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPC
|
surfactant protein C
|
|
SFTPD
|
surfactant protein D
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGPL1
|
sphingosine-1-phosphate lyase 1
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
|
SIGLEC14
|
sialic acid binding Ig-like lectin 14
|
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIGLEC9
|
sialic acid binding Ig-like lectin 9
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIN3B
|
SIN3 transcription regulator family member B
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT6
|
sirtuin 6
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC13A3
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6
|
|
SLC22A8
|
solute carrier family 22 (organic anion transporter), member 8
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC44A4
|
solute carrier family 44, member 4
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SP1
|
Sp1 transcription factor
|
|
SPACA3
|
sperm acrosome associated 3
|
|
SPANXB1
|
SPANX family, member B1
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR2A
|
small proline-rich protein 2A
|
|
SPRTN
|
SprT-like N-terminal domain
|
|
SPX
|
spexin hormone
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
SST
|
somatostatin
|
|
SSTR2
|
somatostatin receptor 2
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STC1
|
stanniocalcin 1
|
|
STMN1
|
stathmin 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYF2
|
SYF2 pre-mRNA-splicing factor
|
|
SYK
|
spleen tyrosine kinase
|
|
SYP
|
synaptophysin
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAC4
|
tachykinin 4 (hemokinin)
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TAOK1
|
TAO kinase 1
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS1R1
|
taste receptor, type 1, member 1
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TAS2R1
|
taste receptor, type 2, member 1
|
|
TAS2R43
|
taste receptor, type 2, member 43
|
|
TBC1D10C
|
TBC1 domain family, member 10C
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBX21
|
T-box 21
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCEB1
|
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TEC
|
tec protein tyrosine kinase
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TEX101
|
testis expressed 101
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFF2
|
trefoil factor 2
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM1
|
transglutaminase 1
|
|
TGM2
|
transglutaminase 2
|
|
TGM3
|
transglutaminase 3
|
|
TGM6
|
transglutaminase 6
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TIMELESS
|
timeless circadian clock
|
|
TIPIN
|
TIMELESS interacting protein
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM173
|
transmembrane protein 173
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TNKS2
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TOM1
|
target of myb1 (chicken)
|
|
TOMM70A
|
translocase of outer mitochondrial membrane 70 homolog A (S. cerevisiae)
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TOPORS
|
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPBG
|
trophoblast glycoprotein
|
|
TPD52
|
tumor protein D52
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRB
|
T cell receptor beta locus
|
|
TRD
|
T cell receptor delta locus
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIM23
|
tripartite motif containing 23
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIM56
|
tripartite motif containing 56
|
|
TRIM7
|
tripartite motif containing 7
|
|
TRIP11
|
thyroid hormone receptor interactor 11
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TROVE2
|
TROVE domain family, member 2
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM5
|
transient receptor potential cation channel, subfamily M, member 5
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTK
|
TTK protein kinase
|
|
TUT1
|
terminal uridylyl transferase 1, U6 snRNA-specific
|
|
TXK
|
TXK tyrosine kinase
|
|
TXN
|
thioredoxin
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
TYK2
|
tyrosine kinase 2
|
|
TYR
|
tyrosinase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBXN11
|
UBX domain protein 11
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
ULBP1
|
UL16 binding protein 1
|
|
UNC93B1
|
unc-93 homolog B1 (C. elegans)
|
|
UPK3A
|
uroplakin 3A
|
|
USP11
|
ubiquitin specific peptidase 11
|
|
USP15
|
ubiquitin specific peptidase 15
|
|
UTS2
|
urotensin 2
|
|
VASN
|
vasorin
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VIMP
|
VCP-interacting membrane selenoprotein
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VPS39
|
vacuolar protein sorting 39 homolog (S. cerevisiae)
|
|
VRK1
|
vaccinia related kinase 1
|
|
VRK2
|
vaccinia related kinase 2
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WARS
|
tryptophanyl-tRNA synthetase
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF1
|
WAS protein family, member 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBP1
|
Z-DNA binding protein 1
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZC3HAV1
|
zinc finger CCCH-type, antiviral 1
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZNHIT1
|
zinc finger, HIT-type containing 1
|
